Description
BCX 1470 is a potent and selective Serine protease inhibitor. CX 1470 blocks the esterolytic and hemolytic activities of the complement enzymes Cls and factor D in vitro, also blocked development of RPA-induced edema in the rat. BCX 1470 may be useful as an anti-inflammatory agent in diseases where complement activation is known to be detrimental.
Product information
CAS Number: 217099-44-0
Molecular Weight: 398.48
Formula: C15H14N2O5S3
Chemical Name: 2-carbamimidoyl-1-benzothiophen-6-yl thiophene-2-carboxylate; methanesulfonic acid
Smiles: CS(O)(=O)=O.NC(=N)C1=CC2=CC=C(C=C2S1)OC(=O)C1=CC=CS1
InChiKey: MCPAUXMAIOICMC-UHFFFAOYSA-N
InChi: InChI=1S/C14H10N2O2S2.CH4O3S/c15-13(16)12-6-8-3-4-9(7-11(8)20-12)18-14(17)10-2-1-5-19-10;1-5(2,3)4/h1-7H,(H3,15,16);1H3,(H,2,3,4)
Technical Data
Appearance: Solid Power
Purity: ≥98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥360 days if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined
HS Tariff Code: 382200
Products are for research use only. Not for human use.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.